Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
摘要
The invention provides methods for predicting therapeutic responsiveness of a subject suffering from cognitive impairments or dysfunctions, psychotic and/or neurodegenerative disorders to an alpha 7 nicotinic acetylcholine receptor activator treatment.
申请公布号
AU2012324458(B2)
申请公布日期
2016.05.19
申请号
AU20120324458
申请日期
2012.10.18
申请人
NOVARTIS AG
发明人
FEUERBACH, DOMINIK;GOMEZ-MANCILLA, BALTAZAR;HE, YUNSHENG;JOHNS, DONALD;LOPEZ-LOPEZ, CRISTINA;MCALLISTER, KEVIN HALL;PEZOUS, NICOLE;SANDFORD, LISA;WEISS, MARKUS
